GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹-1,502 Cr | ₹297 Cr | ₹942 Cr | ₹970 Cr | ₹776 Cr |
What is the latest Consolidated Net Profit of GLENMARK PHARMACEUTICALS ?
Year | Consolidated Net Profit |
---|---|
Mar2025 | ₹-1,502 Cr |
Mar2024 | ₹297 Cr |
Mar2023 | ₹942 Cr |
Mar2022 | ₹970 Cr |
Mar2021 | ₹776 Cr |
How is Consolidated Net Profit of GLENMARK PHARMACEUTICALS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2025 | ₹-1,502 Cr | Negative | |
Mar2024 | ₹297 Cr | -68.44 | |
Mar2023 | ₹942 Cr | -2.92 | |
Mar2022 | ₹970 Cr | 25.01 | |
Mar2021 | ₹776 Cr | - |
Compare Consolidated Net Profit of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹54,413.8 Cr | -1.4% | -10.5% | 12.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹375,100.0 Cr | -5.6% | -9.9% | -12.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,698.0 Cr | -2.5% | -8.4% | 21.7% | Stock Analytics | |
CIPLA | ₹128,239.0 Cr | -0.8% | 1.8% | -1.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,216.0 Cr | -2.4% | -4% | 4.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,855.0 Cr | -0.3% | -0.9% | -9.7% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | -1.4% |
-10.5% |
12.7% |
SENSEX | -1.2% |
-1.2% |
-1.7% |
You may also like the below Video Courses